Ticlopidine Hydrochloride (Caraco Pharmaceutical Laboratories, Ltd.)
Welcome to the PulseAid listing for the Ticlopidine Hydrochloride drug offered from Caraco Pharmaceutical Laboratories, Ltd.. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Caraco Pharmaceutical Laboratories, Ltd. |
NON-PROPRIETARY NAME: | Ticlopidine Hydrochloride |
SUBSTANCE NAME: | TICLOPIDINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2002-09-26 |
END MARKETING DATE: | 0000-00-00 |
Ticlopidine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Ticlopidine Hydrochloride from Caraco Pharmaceutical Laboratories, Ltd. |
LABELER NAME: | Caraco Pharmaceutical Laboratories, Ltd. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2002-09-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 57664-327_aa3b8a6e-c60c-47e3-8ccf-54d73c7e42aa |
PRODUCT NDC: | 57664-327 |
APPLICATION NUMBER: | ANDA075526 |
Other TICLOPIDINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: